European stocks edged higher Tuesday as markets stabilised following a global sell-off triggered by concerns about China’s potential AI breakthrough. Investors across the continent regained confidence, buoyed by positive developments in the biopharmaceutical sector and resilience in key industries.
The Stoxx 600 index rose 0.6% by midday in London, reflecting renewed optimism across European equities. Technology stocks posted a 0.9% gain, recovering some of the ground lost during the broader sell-off. Utilities led the charge, climbing 1.6% as defensive sectors garnered attention amidst global uncertainty.
Among standout performers, biopharmaceutical leader Sartorius delivered a remarkable 14% surge, making it the top mover on the Stoxx 600. The company’s preliminary full-year release revealed it had successfully met profitability targets, further solidifying its financial standing. Additionally, Sartorius projected a “cautiously positive” outlook for 2025, offering reassurance to investors amid an unpredictable global landscape.
As European markets stabilise, Sartorius’ strong performance exemplifies the resilience and innovation driving growth in the region’s biopharma sector, even as global AI developments continue to influence sentiment.
Sartorius is a global leader in biopharmaceutical solutions, providing cutting-edge technologies and services that support the development and production of life-saving therapies.
Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.